Funding Opportunities
Biological and Chemical Defense
Cancer Reasearch
Central Nervous System
Complementary and Alternative Medicine
Dental/Craniofacial
Endocrinology
Gastroenterology
General
Immunology
Infectious Disease
Military Health
Neurology
Oncology
Orthopaedics
Pain Management
Pharmaceuticals
Psychological Health
Stem Cell Research
Technology
Urology
Women's Health
Wound Healing

Grant Application Forms

Funding Agencies

Policies

FAQ





 Biological and Chemical Defense

Agency:          BAA- Broad Agency Announcement; Edgewood Chemical Biological Center

Number:         BAA ECBC-11

Deadline:        Concept papers required; encouraged early in the fiscal year

URL:               http://www.ecbc.army.mil/about/download/Baa2004.doc

 

The U.S. Army Edgewood Chemical Biological Center (ECBC) is the nation’s principal research and development resource for non-medical chemical and biological (CB) defense. As a critical national asset in the CB defense community, ECBC supports all phases of the acquisition life-cycle ¯ from basic and applied research through technology development, engineering design, equipment evaluation, product support, sustainment, field operations and demilitarization ¯ to address its customers’ unique requirements.  Areas of interest include: Biotechnology; Aerosol Technology; Biological Point Detection; Chemical Point Detection; Early Warning and Detection; Smoke and Obscurants; Modeling, Simulation and Analysis for CB, Smoke and Obscurants; Collective Protection Technology; Respiratory Protection Technology; Decontamination; Chemical, Biological, Radiological, Nuclear and Explosive  Countermeasures to Terrorism; Flame and Incendiary Technology; Explosives Point, Proximal and Standoff Detection; Chemical Forensics; and Surface Science

 

Agency:          NIH-National Institutes of Health

Number:         RFA-AI-12-017

Deadline:        Letter of Intent: April 24, 2012

                        Full Application: May 24, 2012

Mechanism:   R01

URL:               http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-017.html

 

This Funding Opportunity Announcement (FOA) issued by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), invites research applications for projects that support preclinical development of lead candidate therapeutics or diagnostics against NIAID Category A, B, or C priority agents. Applications must include a Product Development Strategy attachment and demonstrate substantive investment by at least one industrial participant. 

Home | About the SRSP | For the Investigator | News

  
© Copyright 2006 The Geneva Foundataion